Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic

被引：26
|
作者：
Hansel, K. [1 ]
Patruno, C. [2 ]
Antonelli, E. [1 ]
Dal Bello, G. [3 ]
Napolitano, M. [4 ]
Fabbrocini, G. [5 ]
Grieco, T. [6 ]
Pellacani, G. [6 ]
Fargnoli, M. C. [7 ]
Esposito, M. [7 ]
Piras, V. [8 ]
Zucca, M. [8 ]
Girolomoni, G. [3 ]
Stingeni, L. [1 ]
机构：
[1] Univ Perugia, Dermatol Sect, Dept Med & Surg, Perugia, Italy
[2] Magna Graecia Univ Catanzaro, Sect Dermatol, Hlth Sci Dept, Catanzaro, Italy
[3] Univ Verona, Sect Dermatol & Venereol, Dept Med, Verona, Italy
[4] Univ Molise, Dept Med & Hlth Sci Vincenzo Tiberio, Campobasso, Italy
[5] Univ Naples Federico II, Sect Dermatol, Dept Clin Med & Surg, Naples, Italy
[6] Sapienza Univ Rome, Dermatol Unit, Rome, Italy
[7] Univ LAquila, Dept Biotechnol & Appl Clin Sci, Dermatol, Laquila, Italy
[8] Univ Cagliari, Dept Med Sci & Publ Hlth, Dermatol Clin, Cagliari, Italy
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2022年 / 47卷 / 01期
关键词：
D O I：
10.1111/ced.14862
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：165 / 167
页数：3
相关论文
共 50 条
  • [1] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kim, Nicole S.
    Maliyar, Khalad
    Oliveira, Luciana
    O'Toole, Ashley
    Gooderham, Melinda J.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
  • [2] Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience
    Stingeni, L.
    Bianchi, L.
    Antonelli, E.
    Caroppo, E. S.
    Ferrucci, S. M.
    Ortoncelli, M.
    Fabbrocini, G.
    Nettis, E.
    Schena, D.
    Napolitano, M.
    Gola, M.
    Bonzano, L.
    Rossi, M.
    Fortina, A. Belloni
    Balato, A.
    Peris, K.
    Foti, C.
    Guarneri, F.
    Romanelli, M.
    Patruno, C.
    Savoia, P.
    Fargnoli, M. C.
    Russo, F.
    Errichetti, E.
    Bianchelli, T.
    Bianchi, L.
    Pellacani, G.
    Feliciani, C.
    Offidani, A.
    Corazza, M.
    Micali, G.
    Milanesi, N.
    Malara, G.
    Chiricozzi, A.
    Tramontana, M.
    Hansel, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (08) : 1292 - 1299
  • [3] A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis
    Napolitano, Maddalena
    Fabbrocini, Gabriella
    Potestio, Luca
    Fontanella, Giuseppina
    Picone, Vincenzo
    Bennardo, Luigi
    Scalvenzi, Massimiliano
    Patruno, Cataldo
    DERMATOLOGIC THERAPY, 2022, 35 (08)
  • [4] Atopic dermatitis in adolescents: Effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in Italy
    Stingeni, Luca
    Hansel, Katharina
    Antonelli, Elettra
    Bello, Giacomo Dal
    Patruno, Cataldo
    Napolitano, Maddalena
    Fabbrocini, Gabriella
    Grieco, Teresa
    Pellacani, Giovanni
    Fargnoli, Maria Concetta
    Esposito, Maria
    Piras, Viviana
    Zucca, Myriam
    Girolomoni, Giampiero
    DERMATOLOGIC THERAPY, 2021, 34 (05)
  • [5] A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis
    Stingeni, Luca
    Bianchi, Leonardo
    Antonelli, Elettra
    Caroppo, Elena Sofia
    Ferrucci, Silvia Mariel
    Gurioli, Carlotta
    Ortoncelli, Michela
    Fabbrocini, Gabriella
    Nettis, Eustachio
    Schena, Donatella
    Napolitano, Maddalena
    Gola, Massimo
    Bonzano, Laura
    Rossi, MariaTeresa
    Belloni Fortina, Anna
    Balato, Anna
    Peris, Ketty
    Foti, Caterina
    Guarneri, Fabrizio
    Romanelli, Marco
    Patruno, Cataldo
    Savoia, Paola
    Esposito, Maria
    Russo, Filomena
    Errichetti, Enzo
    Bianchelli, Tommaso
    Bianchi, Luca
    Pellacani, Giovanni
    Feliciani, Claudio
    Offidani, Annamaria
    Corazza, Monica
    Micali, Giuseppe
    Milanesi, Nicola
    Malara, Giovanna
    Chiricozzi, Andrea
    Tramontana, Marta
    Hansel, Katharina
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (03) : E384 - E388
  • [6] Real-world effectiveness and safety of dupilumab in managing children and adolescents with moderate-to-severe atopic dermatitis
    Marshall, Claire
    Littlewood, Zoe
    Herety, Nichola
    Heal, Calvin
    Sharif, Jennifer
    Clayton, Tim
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 196 - 196
  • [7] Real-World Experience and Laboratory Monitoring of Dupilumab in Patients with Moderate to Severe Atopic Dermatitis in a Tertiary Centre
    Kreeshan, Firas Constantin
    Al-Janabi, Ali
    Warren, Richard Bruce
    Hunter, Hamish John Alexander
    DERMATOLOGY AND THERAPY, 2021, 11 (01) : 149 - 160
  • [8] Real-world experience of dupilumab for patients with moderate-to-severe atopic dermatitis in a tertiary care setting
    Kreeshan, F. C.
    Lavery, D.
    Clarke, S.
    Warren, R. B.
    Hunter, H. J. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 70 - 70
  • [9] Real-World Experience and Laboratory Monitoring of Dupilumab in Patients with Moderate to Severe Atopic Dermatitis in a Tertiary Centre
    Firas Constantin Kreeshan
    Ali Al-Janabi
    Richard Bruce Warren
    Hamish John Alexander Hunter
    Dermatology and Therapy, 2021, 11 : 149 - 160
  • [10] Real-world experience of dupilumab treatment for atopic dermatitis
    Martinez Mariscal, Jaime
    Cabana-Navia, Raquel
    Martinez-Fernandez, Alicia
    Martin-Fuentes, Adriana
    Checa-Recio, Ivan
    Gonzalez-Munoz, Patricia
    Sanchez-Herreros, Consuelo
    Vergara, Aranzazu
    Pastor-Nieto, Maria-Antonia
    Eusebio-Murillo, Esther
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB199 - AB199
12345